Revenue, last quarter
$24M
+10.4% vs same quarter last year
Net income
−$8M
+7.8% vs same quarter last year
EPS, diluted
−$0.75
+35.3% vs same quarter last year
Operating cash flow
−$7.2M
+18.9% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $88.5M | −$35.3M |
| FY24 | $71.3M | −$42.9M |
| FY23 | $49.1M | −$52.1M |
| FY22 | $38.2M | −$65.4M |
| FY21 | $54.5M | −$43.2M |
| FY20 | $45.6M | −$65.4M |
| FY19 | $24.6M | −$30.7M |
| FY18 | - | - |
- Operating margin
- Net margin
Show the numbers
| Year | Operating margin | Net margin |
|---|---|---|
| FY25 | −31.5% | −39.9% |
| FY24 | −48.4% | −60.2% |
| FY23 | −84.2% | −106.2% |
| FY22 | −132.4% | −171.3% |
| FY21 | −75.1% | −79.2% |
| FY20 | −50.3% | −143.7% |
| FY19 | −108.9% | −125.1% |
| FY18 | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$23.5M |
| FY24 | −$51.9M |
| FY23 | −$45.8M |
| FY22 | −$48.3M |
| FY21 | −$30.5M |
| FY20 | −$23.3M |
| FY19 | −$23M |
| FY18 | - |
- Biodesix
- Healthcare median
Show the numbers
| Year | Biodesix | Healthcare median |
|---|---|---|
| FY25 | −39.9% | −30.6% |
| FY24 | −60.2% | −47% |
| FY23 | −106.2% | −58% |
| FY22 | −171.3% | −80.4% |
| FY21 | −79.2% | −71.8% |
| FY20 | −143.7% | −62.2% |
| FY19 | −125.1% | −46.2% |
| FY18 | - | −49.6% |